Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Connected moments: capturing patient experience

Capturing an experience when it occurs can give a more accurate and immediate recall

- PMLiVE

Novartis expands eyecare partnership with NHS

And wins new licence for Lucentis

National Institute for Health and Care Excellence NICE logo

Remicade, Humira and Simponi face NICE knock-back

Draft guidance does not recommend the drugs for ulcerative colitis

- PMLiVE

AZ sets up joint lab with Cancer Research UK

Five-year collaboration will drive charity’s research programmes

- PMLiVE

Gilead will file safer HIV combination before year-end

New version of Stribild is less likely to cause side effects

- PMLiVE

Razorfish Healthware forms mHealth partnership with app software firm

Teams up with Stamplay

- PMLiVE

Celgene’s Otezla gains new US psoriasis approval

FDA backs oral drug in moderate to severe plaque psoriasis

- PMLiVE

Almac Group appoints two marketing directors

Matt Cocking and Laura Montgomery join the contract development and manufacturing company

- PMLiVE

Almost half of cancer patients diagnosed ‘too late’

Cancer Research UK claims 46% are diagnosed at advanced stage

- PMLiVE

Moral diversity in healthcare

Should religious or moral beliefs influence a doctor's decision?

- PMLiVE

Ogilvy expands its pharma offering in the Middle East and North Africa

New Dubai operation will be led by Karen Kamel

- PMLiVE

NICE backs Celgene’s Revlimid in rare blood cancer

Patient access scheme sways the HTA body

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links